Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Normodigest Classic
- Development stage
- Unknown
- Lead developer
- Derbós
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Normodigest Classic is a symbiotic dietary supplement developed by Derbos, formulated to support and regenerate the intestinal microbiota. It contains a complex of 15 probiotic strains (7,500 million CFU) including various Lactobacillus and Bifidobacterium species, paired with fructooligosaccharides (FOS) which serve as prebiotics. The liquid formulation also includes medicinal plant extracts—lemon balm (Melissa officinalis), green anise (Pimpinella anisum), and cat's tail (Sideritis tragoriganum)—alongside Vitamin C. It is primarily used to restore gut flora balance after antibiotic use, during periods of stress, or following digestive infections, aiming to improve nutrient assimilation and strengthen the immune system.
- Brand names
- Normodigest Classic
- Other names
- Normodigest
Beyond the preview
Go deeper on Normodigest Classic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Normodigest Classic.